Matthew Walls: CARDIO inCode-Score Presented at AHA25
Matthew Walls, Chief Executive Officer at GENinCode, shared on LinkedIn:
”We are delighted to announce another milestone for CARDIO inCode-Score (polygenic risk score) presented at this weekend’s American Heart Association (AHA) Scientific Sessions Conference in New Orleans. The presentation from Kaiser Permanente showed the latest ASCVD clinical prediction tool ‘PREVENT, was enhanced by the inclusion CARDIO inCode-Score (PRS) providing improved accuracy in personalised risk assessment for prevention of coronary heart disease (CHD). The ASCVD risk prediction tool ‘PREVENT’ estimates a persons risk of developing heart disease.
The presentation showed that integrating CARDIO inCode-Score with PREVENT improves prediction of CHD events. The benefits were particularly evident amongst borderline and intermediate PREVENT risk individuals, where there is uncertainty in clinical decision-making regarding statin initiation or intensification.
We have been working with Kaiser Permanente on the clinical research and development of CARDIO inCode-Score (PRS) for over 15 years. This multi-ancestry population study on over 60,000 individuals, 30-74 years of age with follow up over 14 years, is the latest in a series of clinical utility publications from Kaiser Permanente Departments of Research and Cardiology. Our thanks to Dr. Jamal Rana and Dr. Carlos Iribarren for leading this clinical research and to co-authors Dr. Meng Lu, Dr. Martha Gulati, Dr. Nathan Wong, Dr. Roberto Elosua and our clinical advisory team for championing the inclusion of genetic risk assessment in CHD risk assessment.
CARDIO inCode-Score is a clinically validated, commercially available polygenic risk score using DNA extracted from a simple saliva or blood sample. The test has been designed and optimized for multi-ethnic population-based risk prediction and primary prevention of CHD across international healthcare systems.”
Stay updated with Hemostasis Today.
-
May 24, 2026, 17:48Flora Peyvandi: Crucial Role of Placental ADAMTS13 in Perinatal Survival
-
May 24, 2026, 17:13Mahtab Mashayekhi: The Evolving Role of Red Blood Cell Exchange in the Management of SCD
-
May 24, 2026, 17:12Silvina Graña: Helping Families Better Understand Hemophilia and Daily Life With Bleeding Disorders
-
May 24, 2026, 17:11Miikka Vikkula: Key Insights from the ISSVA 2026 World Congress
-
May 24, 2026, 17:10Mathieu Jackson: Proud to Be Present at This Historic Moment for the Global Bleeding Disorders Community
-
May 24, 2026, 17:09Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration